{
    "nct_id": "NCT06326463",
    "official_title": "CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies",
    "inclusion_criteria": "Inclusion Criteria\n\nAge ≤21 years old\n\nRelapsed/refractory CD70+ hematological malignancy\n\nRelapsed disease: Patients developing recurrent disease after a prior complete remission (CR)\n\nRefractory disease: Patients with persistent disease despite 3 cycles of induction chemotherapy.\n\n* Relapsed/refractory CD70+ AML or MDS:\n\n  * Relapsed disease that is CD70 positive\n  * Refractory disease that is persistent despite 3 cycles of chemotherapy\n* Relapsed/refractory CD70+ B-cell ALL:\n\n  * Relapsed disease that is CD70 positive and CD19 negative/dim or patients otherwise ineligible for CD19-directed therapies including:\n  * Patients in 2nd or greater relapse\n  * Patients with relapse after allogeneic HSCT\n* Relapsed/refractory CD70+ T-cell ALL:\n\n  * Relapsed /refractory disease that is CD70 positive\n* Mixed Phenotype Acute Leukemia (MPAL):\n\n  * Relapsed/refractory that is CD70 positive\n* Relapsed/refractory CD70+ lymphoma:\n\n  * Relapsed disease that is CD70 positive and CD19 negative/dim or patients otherwise ineligible for CD19-directed therapies including:\n  * Patients in 2nd or greater relapse\n  * Patients with relapse after allogeneic HSCT\n\nEstimated life expectancy of >12 weeks\n\nKarnofsky or Lansky (age- dependent) performance score ≥50\n\nPatients with a history of prior allogeneic HCT must be clinically recovered from prior HCT therapy, have no evidence of active GVHD and have not received a donor lymphocyte infusion (DLI) within the 28 days prior to apheresis\n\nPatient must have an identified HCT donor\n\nFor females of childbearing age:\n\ni. Not lactating with intent to breastfeed\n\nii. Not pregnant with negative serum or urine pregnancy test within 7 days prior to enrollment\n\nExclusion Criteria\n\n* Known primary immunodeficiency\n* Known history of HIV positivity\n* Severe intercurrent bacterial, viral or fungal infection\n* History of hypersensitivity to cornstarch or hydroxyethyl starch\n* Patients with acute promyelocytic leukemia (APL)\n* Known contraindication to protocol defined lymphodepleting\n* chemotherapy regimen of Fludarabine/cyclophosphamide\nHealthy volunteers allowed\nMust have maximum age of 21 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}